PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 15.366
AS - Asia 7.476
EU - Europa 6.316
SA - Sud America 1.219
Continente sconosciuto - Info sul continente non disponibili 624
AF - Africa 174
OC - Oceania 16
AN - Antartide 1
Totale 31.192
Nazione #
US - Stati Uniti d'America 14.655
SG - Singapore 2.677
IT - Italia 1.849
CN - Cina 1.645
HK - Hong Kong 984
BR - Brasile 911
VN - Vietnam 899
RU - Federazione Russa 869
DE - Germania 855
SE - Svezia 577
CA - Canada 550
IE - Irlanda 519
UA - Ucraina 332
FR - Francia 313
GB - Regno Unito 288
IN - India 249
BD - Bangladesh 237
AT - Austria 214
FI - Finlandia 117
AR - Argentina 116
TR - Turchia 102
IQ - Iraq 99
KR - Corea 98
JP - Giappone 96
ID - Indonesia 82
NL - Olanda 75
MX - Messico 73
ES - Italia 68
DK - Danimarca 65
ZA - Sudafrica 60
CO - Colombia 51
PK - Pakistan 47
SA - Arabia Saudita 47
VE - Venezuela 39
EC - Ecuador 35
UZ - Uzbekistan 35
PL - Polonia 33
JM - Giamaica 26
EG - Egitto 21
PY - Paraguay 21
MY - Malesia 20
PH - Filippine 20
CH - Svizzera 19
CL - Cile 19
MA - Marocco 17
NP - Nepal 17
ET - Etiopia 16
BE - Belgio 15
CR - Costa Rica 15
DZ - Algeria 15
GR - Grecia 15
PE - Perù 14
PT - Portogallo 14
PS - Palestinian Territory 13
LT - Lituania 12
OM - Oman 12
TH - Thailandia 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
TN - Tunisia 11
PA - Panama 10
TT - Trinidad e Tobago 10
KE - Kenya 9
IL - Israele 8
IR - Iran 8
RO - Romania 8
UY - Uruguay 8
AL - Albania 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
NO - Norvegia 7
DO - Repubblica Dominicana 6
JO - Giordania 6
RS - Serbia 6
AZ - Azerbaigian 5
EU - Europa 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
BO - Bolivia 4
CY - Cipro 4
HN - Honduras 4
LV - Lettonia 4
NI - Nicaragua 4
SC - Seychelles 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
GT - Guatemala 3
HR - Croazia 3
MM - Myanmar 3
NG - Nigeria 3
PR - Porto Rico 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
EE - Estonia 2
Totale 30.533
Città #
Ann Arbor 2.328
Singapore 1.627
Ashburn 1.389
Hong Kong 963
San Jose 851
Woodbridge 671
Fairfield 670
Chandler 562
Dallas 541
Frankfurt am Main 505
Dublin 502
Houston 497
Wilmington 475
Milan 442
Toronto 377
New York 352
Seattle 311
Jacksonville 305
Santa Clara 285
Beijing 277
Ho Chi Minh City 276
Dearborn 262
Council Bluffs 261
Los Angeles 224
Cambridge 222
Chicago 216
Phoenix 199
Princeton 195
Vienna 193
The Dalles 192
Hefei 184
Hanoi 177
Nanjing 143
Rome 142
Lauterbourg 113
São Paulo 94
Altamura 92
Lawrence 92
Seoul 90
Buffalo 81
Moscow 77
Boardman 75
Shanghai 72
Columbus 61
San Diego 56
Tokyo 55
Guangzhou 51
Jakarta 50
Orem 49
Dong Ket 48
Lachine 43
London 43
Nanchang 43
Brooklyn 40
Baghdad 39
Helsinki 39
Da Nang 38
Falls Church 38
Haiphong 36
Montreal 36
Atlanta 33
Munich 33
Lissone 32
Nuremberg 32
Pune 32
Shenyang 32
Tashkent 32
Andover 31
Jinan 31
San Francisco 30
Tianjin 29
Turin 29
Denver 28
Changsha 27
Salt Lake City 27
Ottawa 26
Boston 25
Naples 25
Tampa 25
Zhengzhou 25
Dhaka 24
Warsaw 24
Washington 24
Figino 23
Johannesburg 23
Jeddah 22
Rio de Janeiro 21
Belo Horizonte 20
Chennai 20
Hebei 20
Manchester 20
New Delhi 20
Philadelphia 20
Ningbo 19
Brasília 18
Florence 18
Hangzhou 18
Istanbul 18
Mumbai 18
Bologna 17
Totale 19.358
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 736
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 545
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 535
Microscopic Polyangiitis 461
The putative role of MALDI-MSI in the study of Membranous Nephropathy 456
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 424
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 415
MALDI imaging in Fabry nephropathy: a multicenter study 414
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 407
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 395
Kidney Involvement 395
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 383
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 383
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 382
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 370
Proteomics for the study of new biomarkers in Fabry disease: State of the art 362
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 339
Usefulness of waist circumference for the identification of childhood hypertension 338
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 332
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 325
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 320
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 314
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 311
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 307
Obesity-associated hypertension in childhood: A new epidemic problem 303
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 303
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 298
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 296
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 294
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 291
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 290
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 286
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 281
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 278
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 276
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 273
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 272
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 267
Sympathetic activation in cardiovascular and renal disease 265
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 263
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 260
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 259
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 257
Parapelvic cysts, a distinguishing feature of renal Fabry disease 257
Role of fat distribution indicators in the identification of hypertension in children 253
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 252
Interpretation of GFR slope in untreated and treated adult Fabry patients 250
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 250
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 250
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 250
Anticoagulant-related nephropathy: a pathological note 248
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 242
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 240
Tumour incidence in Fabry disease: A cross-sectional study 240
Avacopan for the treatment of ANCA-associated vasculitis 240
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 239
Renal afferents signaling diuretic activity in the cat 239
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 239
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 239
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 237
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 237
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 237
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 233
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 231
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 228
La terapia enzimatica sostitutiva nella malattia di Fabry 226
ANCA-associated vasculitis in childhood: Recent advances 221
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 220
Redefining the pulvinar sign in fabry disease 216
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 215
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 214
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 213
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 213
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 212
Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment 211
[Clinical and histological findings in Fabry nephropathy] 211
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 210
Hypertension in childhood: autonomic and metabolic patterns 210
La diagnosi precoce di malattia 208
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 207
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 206
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 202
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 198
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 198
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 196
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 195
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 194
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 193
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 193
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 193
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 188
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 187
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 184
Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy 184
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 184
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 183
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis 177
Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs 176
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 176
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 172
Totale 27.278
Categoria #
all - tutte 100.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.074 0 0 0 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20254.413 266 395 261 189 345 148 270 133 511 813 402 680
2025/202610.804 1.145 705 1.059 976 1.185 499 1.470 550 840 815 739 821
2026/20272.521 450 570 1.359 142 0 0 0 0 0 0 0 0
Totale 31.192